Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Novel Treatments for Metabolic Bone Diseases

Presentations in This Video

Novel Treatments for Metabolic Bone Diseases - TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension

Mishaela R Rubin, MD

Columbia University, NJ, United States

Novel Treatments for Metabolic Bone Diseases - Burosumab Provides Sustained Improvement in Phosphorus Homeostasis and Heals Rickets in Children Aged 1 to 4 Years With X-Linked Hypophosphatemia (XLH)

Gary Gottesman, MD

Shriners Hospitals for Children, MO, United States

Novel Treatments for Metabolic Bone Diseases - Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa

Melanie S Haines, MD

Massachusetts General Hospital/Harvard Medical School, MA, United States

Novel Treatments for Metabolic Bone Diseases - Chair

Suzanne Marie Jan De Beur, MD

Johns Hopkins University School of Medical, MD, United States

Novel Treatments for Metabolic Bone Diseases - Garetosmab Reduces Flare-ups in Patients With Fibrodysplasia Ossificans Progressiva

Kathryn McCrystal Dahir, MD

Vanderbilt University, TN, United States

Related Media